Related references
Note: Only part of the references are listed.Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019
Jonathan H. Chow et al.
ANESTHESIA AND ANALGESIA (2021)
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis
Matthew L. Meizlish et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Bioactive lipids in antiviral immunity
Katherine N. Theken et al.
SCIENCE (2021)
The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID-19 infection
Eugene Merzon et al.
FEBS JOURNAL (2021)
Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
Qiang Liu et al.
MEDICINE (2021)
Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration
Thomas F. Osborne et al.
PLOS ONE (2021)
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
John G. Rizk et al.
DRUG DISCOVERY TODAY (2021)
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Betsy J. Barnes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
Leo Nicolai et al.
CIRCULATION (2020)
Pharmaco-Immunomodulatory Therapy in COVID-19
John G. Rizk et al.
DRUGS (2020)
Platelet gene expression and function in patients with COVID-19
Bhanu Kanth Manne et al.
BLOOD (2020)
Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department
Alban Gervaise et al.
EUROPEAN RADIOLOGY (2020)
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
George Goshua et al.
LANCET HAEMATOLOGY (2020)
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
Eugenio D. Hottz et al.
BLOOD (2020)
Authors' Reply to Vrachatis et al. Pharmaco-Immunomodulatory Therapy in COVID-19
John G. Rizk et al.
DRUGS (2020)
Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia
Jacob Herrmann et al.
NATURE COMMUNICATIONS (2020)
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations
Caroline Diorio et al.
BLOOD ADVANCES (2020)
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series
Amy Rapkiewicz et al.
ECLINICALMEDICINE (2020)
Antiviral activity of aspirin against RNA viruses of the respiratory tract-an in vitro study
Bernadette Glatthaar-Saalmueller et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
Luis A. Garcia Rodriguez et al.
PLOS ONE (2016)
Thromboxane A2 receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells
Yoshio Matsui et al.
CANCER SCIENCE (2012)
Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans
Thea Morris et al.
JOURNAL OF IMMUNOLOGY (2009)
Aspirin triggers anti inflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial
N Chiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The adhesion molecule P-selectin and cardiovascular disease
AD Blann et al.
EUROPEAN HEART JOURNAL (2003)
Share Paper
